Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
F. Muecksch, Y. Weisblum, C. Barnes, F. Schmidt, D. Schaefer-Babajew, J. Lorenzi, A. Flyak, A. DeLaitsch, K. Huey-Tubman, S. Hou, C. Schiffer, C. Gaebler, Z. Wang, J. Da Silva, D. Poston, S. Finkin, A. Cho, M. Cipolla, T. Oliveira, K. Millard, V. Ramos, A. Gazumyan, M. Rutkowska, M. Caskey, M. Nussenzweig, , P. Bieniasz
Abstract
Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
T. N. Starr, N. Czudnochowski, … Veesler·bioRxiv·Apr 6, 2021
- Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Z. Liu, L. A. VanBlargan, … S. P. J. Whelan·bioRxiv·Nov 6, 2020
- The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
A. J. Greaney, A. N. Loes, … J. D. Bloom·bioRxiv·Apr 14, 2021
- Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
F. Zhao, C. Keating, … J. G. Jardine·bioRxiv·Jan 6, 2022
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Y. Weisblum, F. Schmidt, … P. D. Bieniasz·bioRxiv·Jul 21, 2020
- Spike conformational tuning rather than epitope erosion drives SARS-CoV-2 resistance to broadly neutralizing antibodies
Riku Fagerlund, Hasan Uğurlu, … Kalle Saksela·bioRxiv·Dec 3, 2024